Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 145, Issue 3, 2007, Pages 293-301

  Moog, Ute ^a,b,c   Van Mierlo, Ingrid ^b   Van Schrojenstein Lantman de Valk, Henny M J ^b,d   Spaapen, Leo ^a   Maaskant, Marian A ^b,d   Curfs, Leopold M G ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Maastricht University ^*

Author keywords

Adult phenotype; Aging; Natural history; Sanfilippo type B

Indexed keywords

ADULT; AGING; ARTHRITIS; ARTICLE; BEHAVIOR DISORDER; BONE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FACIES; FEEDING; FEMALE; FOLLOW UP; HEART DISEASE; HERNIA; HUMAN; INCONTINENCE; MALE; MENTAL DEFICIENCY; PHENOTYPE; PRIORITY JOURNAL; SANFILIPPO SYNDROME; SEIZURE; SKIN DISEASE;

ADOLESCENT; ADULT; BEHAVIORAL SYMPTOMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS III;

EID: 34548087323     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30142     Document Type: Article

References (25)

1. Ashworth JL, Biswas S, Wraith E, Lloyd IC. 2006. Mucopolysaccharidoses and the eye. Surv Ophthalmol 51:1-17.
2. Beesley CE, Jackson M, Young EP, Vellodi A, Winchester BG. 2005. Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB). J Inherit Metab Dis 28: 759-767.
3. Bunge S, Knigge A, Steglich C, Kleijer WJ, van Diggelen OP, Beck M, Gal A. 1999. Mucopolysaccharidosis type IIIB (Sanfilippo B): Identification of 18 novel alpha-N-acetylglucosaminidase gene mutations. J Med Genet 36:28-31.
4. Chinen Y, Tohma T, Izumikawa Y, Uehara H, Ohta T. 2005. Sanfilippo type B syndrome: Five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan. J Hum Genet 50:357-359.
5. Cleary MA, Wraith JE. 1993. Management of mucopolysaccharidosis type III. Arch Dis Child 69:403-406.
6. Colville GA, Walters JP, Yule W, Bax M. 1996. Sleep problems in children with Sanfilippo syndrome. Dev Med Child Neurol 38:538-544.
7. Curry CJ. 2002. Rational evaluation of the adolescent with mental retardation. Adolesc Med 13:331-343.
8. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JMJr, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J. 1997. Evaluation of mental retardation: Recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 72:468-477.
9. Fraser J, Wraith JE, Delatycki MB. 2002. Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): A survey of managing clinicians. Clin Genet 62:418-421.
10. Fraser J, Gason AA, Wraith JE, Delatycki MB. 2005. Sleep disturbance in Sanfilippo syndrome: A parental questionnaire study. Arch Dis Child 90:1239-1242.
11. Garbuzova-Davis S, Willing AE, Desjarlais T, Sanberg CD, Sanberg PR. 2005. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo type B. Stem Cells Dev 14:383-394.
12. Hoefnagel CWM. 1989. OOB. In: Oud en Zwakzinnig. Mentale Retardatie Vanuit Psychologische Optiek. Lisse: Swets & Zeitlinger.
13. Lee Chen GJ, Lin SP, Lin SZ, Chuang CK, Hsiao KT, Huang CF, Lien WC. 2002. Identification and characterisation of mutations underlying Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). J Med Genet 39:E3.
14. Moog U, Schoonbrood-Lenssen AMJ, Wagemans A, Spaapen LJM, de Die-Smulders CEM. 1998. De ziekte van Sanfilippo type B: Ondergediagnosticeerd bij verstandelijk gehandicapten? NTZ 3:161-166.
15. Piotrowska E, Jakobkiewicz Banecka J, Baranska S, Tylki Szymanska A, Czartoryska B, Wegrzyn A, Wegrzyn G. 2006. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14:846-852.
16. Van Buggenhout GJCM, Trijbels JMF, Wevers R, Trommelen JCM, Hamel BCJ, Brunner HG, Fryns JP. 2001. Metabolic studies in older mentally retarded patients: Significance of metabolic testing and correlation with the clinical phenotype. Genet Couns 12:1-21.
17. Van de Kamp JJ, van Pelt JF, Liem KO, Giesberts MA, Niepoth LT, Staalman CR. 1976. Clinical variability in Sanfilippo B disease: A report on six patients in two related sibships. Clin Genet 10:279-284.
18. Van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA. 1981. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152-160.
19. van Schrojenstein de Valk HM, Van de Kamp JJ. 1987. Follow-up on seven adult patients with mild Sanfilippo B-disease. Am J Med Genet 28:125-129.
20. Weber B, Blanch L, Clements PR, Scott HS, Hopwood JJ. 1996. Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B). Hum Mol Genet 5:771-777.
21. Weber B, Guo XH, Kleijer WJ, Van de Kamp JJ, Poorthuis BJ, Hopwood JJ. 1999. Sanfilippo type B syndrome (mucopolysaccharidosis III B): Allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 7:34-44.
22. Yogalingam G, Hopwood JJ. 2001. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Hum Mutat 18: 264-281.
23. Yogalingam G, Weber B, Meehan J, Rogers J, Hopwood JJ. 2000. Mucopolysaccharidosis type IIIB: Characterisation and expression of wild-type and mutant recombinant alpha-N-acetylglucosaminidase and relationship with sanfilippo phenotype in an attenuated patient. Biochim Biophys Acta 1502:415-425.
24. Zhao HG, Aronovich EL, Whitley CB. 1998. Genotype-phenotype correspondence in Sanfilippo syndrome type B. Am J Hum Genet 62:53-63.
25. Zheng Y, Ryazantsev S, Ohmi K, Zhao HZ, Rozengurt N, Kohn DB, Neufeld EF 2004. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab 82:286-295.